Moderna Inc. buy Traumtanz
Start price
20.11.23
/
50%
€72.57
Target price
20.11.24
€74.00
Performance (%)
-2.67%
End price
21.11.23
€70.63
Summary
This prediction ended on 21.11.23 with a price of €70.63. With a performance of -2.67%, the BUY prediction for Moderna Inc. by Traumtanz closed slightly in the red. Traumtanz has a follow-up prediction for Moderna Inc. where he still thinks Moderna Inc. is a Buy. Traumtanz has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Moderna Inc. | 1.635% |
iShares Core DAX® | 2.122% |
iShares Nasdaq 100 | 1.636% |
iShares Nikkei 225® | -0.215% |
iShares S&P 500 | 1.321% |
According to Traumtanz what are the pros and cons of Moderna Inc. for the foreseeable future?
Pros
Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Cons
Comments by Traumtanz for this prediction
In the thread Moderna Inc. diskutieren
Buy mit Kursziel 74,0
In the thread Trading Moderna Inc.
Buy beendet
Current prediction by Traumtanz for Moderna Inc.
Moderna Inc.
Start price
Target price
Perf. (%)
€73.21
02.12.23
02.12.23
€74.00
02.12.24
02.12.24
1.91%
08.12.23
08.12.23
Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Stopped prediction by Traumtanz for Moderna Inc.
Moderna Inc.
Start price
Target price
Perf. (%)
€71.59
24.11.23
24.11.23
€70.00
24.11.24
24.11.24
2.26%
02.12.23
02.12.23
Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Moderna Inc.
Start price
Target price
Perf. (%)
€70.95
23.11.23
23.11.23
€74.00
23.11.24
23.11.24
0.90%
24.11.23
24.11.23
Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Moderna Inc.
Start price
Target price
Perf. (%)
€70.63
21.11.23
21.11.23
€74.00
21.11.24
21.11.24
0.45%
23.11.23
23.11.23
Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Moderna Inc.
Start price
Target price
Perf. (%)
€69.64
31.10.23
31.10.23
€71.00
31.10.24
31.10.24
4.21%
20.11.23
20.11.23
Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Moderna Inc.
Start price
Target price
Perf. (%)
€183.12
18.01.23
18.01.23
€110.00
18.01.24
18.01.24
-61.97%
31.10.23
31.10.23
Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio